Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism.
Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism. Oncotarget. 2015 Nov 10; 6(35):37200-15.
View in:
PubMed
subject areas
Animals
Biomarkers, Tumor
Carcinoma, Hepatocellular
Cell Line, Tumor
Cell Proliferation
Databases, Genetic
Gene Expression Regulation, Neoplastic
Gene Knockdown Techniques
Genetic Therapy
Humans
Intracellular Signaling Peptides and Proteins
Liver Cirrhosis
Liver Neoplasms
Mice, Nude
MicroRNAs
Neoplastic Stem Cells
Phenotype
Retrospective Studies
RNA Interference
RNAi Therapeutics
Signal Transduction
Time Factors
Transcription Factors
Transfection
Tumor Burden
Up-Regulation
Xenograft Model Antitumor Assays
authors with profiles
Naushad Ali
Courtney Wayne Houchen
Dongfeng Qu
Javid Fazili
Kai Ding
Mohammad Farouq Madhoun
Randal Joseph May